NCT07069959

Brief Summary

Patients in intensive care often develop acquired muscle weakness (ICUAW or Intensive Care Unit Acquired Weakness) due to immobilization and muscle atrophy. Early mobilization can help reduce weakness and improve functional recovery, but practices vary. Muscle strength assessment, particularly using the MRC (Medical Research Council) score, is crucial, though it has precision limitations. Additional methods, such as manual dynamometry and functional scales, are needed to better track muscle recovery. The quadriceps, important for function, requires early evaluation, but there is a lack of specific data in intensive care to predict medium-term functional recovery.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
6mo left

Started Aug 2025

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress61%
Aug 2025Nov 2026

First Submitted

Initial submission to the registry

June 24, 2025

Completed
23 days until next milestone

First Posted

Study publicly available on registry

July 17, 2025

Completed
15 days until next milestone

Study Start

First participant enrolled

August 1, 2025

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2026

Last Updated

July 17, 2025

Status Verified

July 1, 2025

Enrollment Period

1.3 years

First QC Date

June 24, 2025

Last Update Submit

July 16, 2025

Conditions

Keywords

dynamometrymuscle weaknessintensive carefunctional recoveryinvasive mechanical ventilation3D ultrasound

Outcome Measures

Primary Outcomes (2)

  • Describe the evolution of quadriceps muscle recovery using manual dynamometry in patients under invasive mechanical ventilation in the ICU.

    This study aims to describe the evolution of quadriceps muscle recovery in ICU patients under invasive mechanical ventilation, using manual dynamometry as a measurement tool. The recovery will be assessed periodically throughout the ICU stay to evaluate early muscle strength recovery.

    3 months

  • Description of the evolution of the recovery of the rectus femoris muscle using 3D ultrasound in ICU patients treated with invasive mechanical ventilation.

    Change in the volume of the rectus femoris muscle measured by 3D ultrasound.

    3 months after ICU discharge

Secondary Outcomes (17)

  • Estimate the average value of the FMQ

    From inclusion to 3 months post-ICU discharge

  • To study the correlation between FMQ values and other muscular and functional scores on the same day.

    From inclusion to 3 months post-ICU discharge

  • Study the differences in muscle strength between right and left FMQ values on the same day

    From inclusion to 3 months post-ICU discharge

  • Study the correlation between FMQ at inclusion and the time until extubation, when the patient was still intubated at inclusion

    From inclusion to the day of extubation, an average of 7 days

  • Study the correlation between FMQ at inclusion and the ability to achieve verticalization for patients who could stand before ICU discharge

    From inclusion to ICU discharge, an average of 10 days

  • +12 more secondary outcomes

Study Arms (1)

Patients under invasive mechanical ventilation in the ICU

This group includes patients admitted to the Intensive Care Unit (ICU) at the CHU of Nantes, treated with invasive mechanical ventilation. The study aims to evaluate the early recovery of quadriceps muscle strength in these patients, using non-invasive, pain-free assessment methods. The cohort will consist of approximately 100 patients over one year, with data collected via the medical record and strength measurements performed by physical therapists.

Other: Early assessment of quadriceps muscle strength

Interventions

Patients will undergo non-invasive assessment of quadriceps muscle strength using manual dynamometry and 3D ultrasound. These assessments will be conducted regularly during their ICU stay to evaluate early recovery. The intervention is part of routine patient care and does not involve additional treatments or procedures.

Patients under invasive mechanical ventilation in the ICU

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The study population includes adults (aged \>18 years) admitted to the ICU and treated with invasive mechanical ventilation for at least 4 days. Participants must be conscious, cooperative, and have an MRC score ≥ 3/5 for "Leg Extension" on either side. Informed consent or no objection is required. Exclusion criteria include pregnancy, neurological disorders, lower limb injuries, or conditions preventing safe participation.

You may qualify if:

  • Adults aged \> 18 years
  • Hospitalized in an ICU
  • Conscious and cooperative patients: ability to respond appropriately to the following commands: open and close eyes, look at me, nod your head, stick out your tongue, raise your eyebrows when I count to five
  • MRC score ≥ 3/5 for the "Leg Extension" function on either the left or right side
  • Informed consent obtained (no opposition)

You may not qualify if:

  • Pregnant or breastfeeding women
  • Fracture or amputation of a lower limb
  • Acute or chronic brain or spinal cord injury responsible for hemiplegia or paraplegia
  • Unstable spinal injury
  • Neurodegenerative or chronic neurological disease
  • Guillain-Barré Syndrome
  • Myasthenia Gravis
  • Acute deep vein thrombosis of the lower limbs treated within the last 48 hours
  • Pre-existing motor deficit in a lower limb before the ICU stay, of any cause
  • Incarcerated or legally protected individuals (guardianship, curatorship)
  • Individuals without social protection

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Nantes University Hospital

Nantes, Loire Atlantique, 44300, France

Location

MeSH Terms

Conditions

Muscle Weakness

Condition Hierarchy (Ancestors)

Muscular DiseasesMusculoskeletal DiseasesNeuromuscular ManifestationsNeurologic ManifestationsNervous System DiseasesPathologic ProcessesPathological Conditions, Signs and SymptomsSigns and Symptoms

Central Study Contacts

Research and Innovation Departement of Nantes UH

CONTACT

Jean REIGNIER, UH Practitioner

CONTACT

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 24, 2025

First Posted

July 17, 2025

Study Start

August 1, 2025

Primary Completion (Estimated)

November 1, 2026

Study Completion (Estimated)

November 1, 2026

Last Updated

July 17, 2025

Record last verified: 2025-07

Locations